Intrathecal Pumps Market Size, Share & Trends Analysis Report By Type (Baclofen, Bupivacaine, Clonidine, Morphine, Ziconotide, Others), By Application (Spasticity, Pain) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Intrathecal Pumps Market Size & Insights

The global intrathecal pumps market size was valued at USD 394.45 million in 2025 and is projected to grow from USD 414.57 million in 2026 to USD 617.19 million by 2034, registering a CAGR of 5.1% during the forecast period from 2026 to 2034. North America dominated the intrathecal pumps market with a market share of 42.5% in 2025.

A growing number of newly diagnosed spinal cancer cases each year, supported by robust cancer screening programs, is anticipated to boost demand for intrathecal pumps, driving market growth over the forecast period.

Intrathecal pumps, also known as intrathecal drug delivery systems or spinal infusion pumps, are implantable medical devices that directly inject drugs into the spinal fluid to manage chronic pain or spasticity. These pumps are specifically designed to target the affected area and provide localized relief by delivering medication directly to the spinal cord. The intrathecal pump system comprises a pump, a reservoir for medication, and a catheter. The pump is usually implanted under the skin in the abdomen or buttocks, while the catheter is placed into the intrathecal space in the spine. The pump is programmable and can be adjusted to deliver a precise amount of medication at scheduled intervals or through patient-controlled settings.

One of the primary applications of intrathecal pumps is in chronic pain management. They are particularly beneficial for patients without sufficient relief from other pain management methods. Conditions such as cancer-related pain failed back surgery syndrome, and neuropathic pain can be effectively managed by delivering opioids or a combination of opioids and local anesthetics directly into the spinal fluid. By targeting the pain receptors in the spinal cord, intrathecal pumps provide targeted pain relief with lower doses of medication, reducing the risk of systemic side effects. In addition to pain management, intrathecal pumps manage severe spasticity. Spasticity is characterized by involuntary muscle contractions and stiffness, often associated with neurological disorders like cerebral palsy, multiple sclerosis, and spinal cord injury. Intrathecal pumps deliver medications such as baclofen, a muscle relaxant, directly to the spinal cord, reducing spasticity and improving muscle control. This localized approach minimizes systemic side effects and allows for more effective spasticity management.

Segmental Analysis

The global market for intrathecal pumps is bifurcated into types and applications.

By Type

The global market is bifurcated into baclofen, bupivacaine, clonidine, morphine, ziconotide, and others.

The baclofen segment dominates the global market and is projected to exhibit a CAGR of 4.2% over the forecast period. Baclofen intrathecal pumps reduce spasticity related to spinal cord injuries, neurological diseases, and multiple sclerosis. Intrathecal pumps aid in delivering baclofen to the target site of the spinal cord, thereby allowing the effective delivery of medicine. The intrathecal baclofen infusion has certain advantages: The oral baclofen administration has certain adverse effects, such as confusion and drowsiness. Intrathecal administration minimizes such effects and provides better outcomes. The intrathecal administration enables a high concentration of drugs in the CSF compared to oral administration; the intrathecal administration allows 100 times lower plasma concentration compared to the oral route of administration.

Furthermore, ongoing research and development efforts focused on optimizing intrathecal baclofen therapy, such as dose titration algorithms and drug delivery techniques, are expected to drive the baclofen segment's growth further. These advancements aim to improve treatment outcomes, reduce adverse effects, and enhance patient satisfaction.

Request Customizationto receive a tailored report.

By Application

The global market is bifurcated into spasticity and pain based on application.

The spasticity segment dominates the global market and is projected to exhibit a CAGR of 4.3% over the forecast period. Spasticity is a movement disorder, majorly caused by conditions that affect the spinal cord and brain, like spinal cord injury, stroke, cerebral palsy, and multiple sclerosis. The major symptoms of this condition are muscle tightness and stiffness, muscle spasms, and clonus. These conditions can be initially treated with local botulinum toxin injections; however, intrathecal baclofen is recommended in case of severe disease.

An increasing number of stroke cases across the globe is also one of the major factors contributing to segment growth. For instance, per a report published by the American College of Cardiology Foundation in 2019, an American suffers from an average stroke every 40 seconds, and around 795,000 Americans have recurrent and new strokes annually. Since spasticity is majorly caused by stroke, increasing stroke cases is anticipated to impact segment growth over the forecast period positively.

Speak to an Analystto discuss market opportunities.

Regional Insights

Based on region, the global intrathecal pumps market share is bifurcated into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.

North America : Dominant Region with 3.9% Cagr

North America is the most significant global market shareholder and is estimated to grow at a CAGR of 3.9% over the forecast period. The increase in the aging population in the region is expected to contribute to the growing number of people opting for spinal surgeries. As per the Population Reference Bureau, in the U.S., people aged 65 years and above are expected to increase twofold from 52 million in 2018 to 95 million by 2060. The older group is at a higher risk of spinal disorders, such as spinal deformities, trauma, degenerative disc disease, tumors, and vertebral compression fractures, which need surgical interventions, thereby driving the volume of spinal surgeries in the region.

However, patients who underwent spinal surgery sometimes experience pain after the surgery, which is called Failed Back Surgery Syndrome (FBSS). Intrathecal pumps help alleviate the chronic pain caused due to FBSS.

Unlock Regional Insightsto access country-level data, & regional trends.

Europe: Fastest Growing Region

Europe is anticipated to exhibit a CAGR of 4.8% over the forecast period. The spinal surgery market is a growing and large market in Europe that involves technological advancements and events such as EUROSPINE 2019. EUROSPINE 2019 is a scientific program that offers ample opportunities to treat and research spine conditions and meet experts worldwide. Such events are expected to contribute to the growing knowledge regarding intrathecal pumps in managing spinal pain. In addition, the growing aging population in Europe is expected to propel the adoption of spinal fusion surgeries. For instance, in 2018, 19.7% of the European population was over 65.

Moreover, the increasing number of spine surgeries will boost the demand for intrathecal pumps for pain management, thereby expected to drive the market. For instance, around 266 million European patients have lower back pain due to lumbar degenerative disease. In 2018, around 62,000 Transforaminal Lumbar Interbody Fusion (TLIF) procedures were performed in Europe.

The large aging population in Asia-Pacific countries like Japan, China, India, and Thailand is expected to drive the overall market. Moreover, the growing prevalence of chronic diseases, like neurological disorders, cancer, and pain associated with these diseases, is also expected to contribute to market growth. Since many patients in the region seek chronic pain management therapies, various medical settings offer these services, mainly in countries like India and South Korea. Moreover, favorable reimbursement policies in countries like South Korea for pain management using intrathecal drug delivery devices may also propel the market growth.

Brazil majorly drives the economy of the Latin American region. Healthcare spending in this region was reported to be around 7.9% of the GDP in 2018, third in terms of healthcare spending after North America and Western Europe. A rise in health awareness and increased demand for technologically advanced medical devices for long-term care are among the key factors expected to boost the market growth. Moreover, an increase in funding for R&D in healthcare and a rise in the prevalence of cancer are some factors expected to drive the market over the forecast period.

Middle Eastern countries, like Saudi Arabia, are prospering economies and are rapidly growing. The expanding health insurance penetration, increasing privatization, and rising disease burden can act as primary factors responsible for the intrathecal pumps market growth. Advancements in the healthcare system are expected to increase the demand for cancer pain management devices in this region. Varying socioeconomic conditions and political developments across the Middle East region are entirely conceivable for companies to find opportunities for R&D in the healthcare industry.

List of Key and Emerging Players in Intrathecal Pumps Market